The survival time of melanoma patients cannot be generalized, but mainly depends on the stage of the tumor, the site of occurrence, the presence of genetic mutations and whether the patient has undergone active and effective treatment, which requires specific analysis. Generally speaking, if a patient has early stage melanoma (stage I and IIA), most patients can be cured by surgery alone and can survive for a long time. If the patient has reached the intermediate or advanced stage, the survival period will be shortened accordingly, but the specific survival rate still varies significantly due to the influence of various factors. For example, patients with primary foci in the extremities have a better prognosis than those with mucosal melanoma, and patients without mutations have a better prognosis than those with mutations. The prognosis of patients without genetic mutations is better than that of patients with mutations, etc. In addition, it depends on whether the patient is sensitive to treatment. In contrast, malignant melanoma that is advanced and insensitive to treatment has a very poor prognosis, with survival time often less than one year. Therefore, for melanoma patients, early diagnosis and early treatment are the keys to improve prognosis and prolong survival. It is recommended that patients must not overly panic, and rational and active treatment with doctors is the best choice to overcome the disease.